Sealfon Ross Bradley sold $783K of ARXS
Sealfon Ross Bradley (See Remarks) sold 15,000 shares of Arxis, Inc. (ARXS) at an average of $52.23 ($51.44–$53.03, $0.78M total) across 3 trades on 2026-11-11.
Arxis, Inc.
Arxis designs and manufactures electronic and mechanical components for specialized applications. Its electronic products include connectors, cable assemblies, microelectronic packaging, radio frequency and microwave equipment, power products, sensors, capacitors, and resistors. Mechanical offerings include precision bearings, seals, springs, gaskets, ducting, and radar-absorbing materials. The company serves defense and space, commercial aerospace, medical technology, semiconductor testing, analytical equipment, and industrial automation markets. Arxis is based in Bloomfield, Connecticut.
Sealfon Ross Bradley (See Remarks) sold 15,000 shares of Arxis, Inc. (ARXS) at an average of $52.23 ($51.44–$53.03, $0.78M total) across 3 trades on 2026-11-11.
Perhamus Kevin Scott (See Remarks) sold 25,000 shares of Arxis, Inc. (ARXS) at an average of $50.92 ($50.59–$51.19, $1.27M total) across 2 trades on 2026-11-09.
Arxis (ARXS) stock fell 7.5% on October 30, 2026, despite reporting Q3 revenue of $564M, up 36% YoY, and raising 2026 guidance to $2.05B-$2.07B. The drop coincided with a broader market decline, including a 1.8% loss in the S&P 500. The company's adjusted EBITDA margin was 45.4%, driven by higher prices and increased sales volume.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning ARXS (Arxis, Inc.). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent ARXS coverage spans financial news, insider activity and earnings.
In the last 30 days, ARXS insiders filed 5 SEC Form 4 transactions — no purchases and 5 sales ($2.1M). The most active reporter was Sealfon Ross Bradley, See Remarks, with 3 filings.
The insider sale may signal reduced confidence from management and could weigh on the stock.
The insider sale may signal reduced confidence and could pressure the stock lower.
Stock decline despite upbeat guidance suggests market skepticism.
Morgan Stanley kept its Overweight rating on Arxis but raised its price target to $66 from $62, suggesting a 20.2% upside from the Oct 29 close of $54.93.
RBC Capital kept its Outperform rating on Arxis and increased its price target to $64 from $60, suggesting a 16.5% upside from the Oct 29 close of $54.93, according to the firm.
AlphAI scores every news story that mentions ARXS with an AI model for sentiment and relevance, and aggregates insider trades from Arxis, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Sealfon Ross Bradley (See Remarks) sold 15,000 shares of Arxis, Inc. (ARXS) at an average of $52.23 ($51.44–$53.03, $0.78M total) across 3 trades on 2026-11-11.
Perhamus Kevin Scott (See Remarks) sold 25,000 shares of Arxis, Inc. (ARXS) at an average of $50.92 ($50.59–$51.19, $1.27M total) across 2 trades on 2026-11-09.
Arxis (ARXS) stock fell 7.5% on October 30, 2026, despite reporting Q3 revenue of $564M, up 36% YoY, and raising 2026 guidance to $2.05B-$2.07B. The drop coincided with a broader market decline, including a 1.8% loss in the S&P 500. The company's adjusted EBITDA margin was 45.4%, driven by higher prices and increased sales volume.
Morgan Stanley kept its Overweight rating on Arxis but raised its price target to $66 from $62, suggesting a 20.2% upside from the Oct 29 close of $54.93.
RBC Capital kept its Outperform rating on Arxis and increased its price target to $64 from $60, suggesting a 16.5% upside from the Oct 29 close of $54.93, according to the firm.
Arxis, Inc.'s average stock price target increased from $64.7 to $65.1, with a range of $60 to $72, implying 19% upside. 11 analysts maintain a 'Buy' rating. Data sourced from FactSet.
Arxis reported Q3 2026 revenue of $564 million, up 36% YoY, with net income of $84 million, compared to a $10 million loss in Q3 2025. Adjusted EBITDA rose 67% to $256 million. The company raised full-year 2026 guidance and introduced 2027 guidance, anticipating continued growth and margin expansion. Recent acquisitions include Omnetics, Schatz Bearing, and StratEdge.
Tesla (TSLA) rose 5% after Q3 deliveries exceeded expectations. Broadcom (AVGO) gained 3% on a $42B loan deal with Anthropic. Nike (NKE) fell 6% due to missed revenue and China sales decline. ON Semiconductor (ON) and Synaptics (SYNA) surged on a revised buyout offer. Other movers include Nexalin, Vylor, Seagate (STX), Western Digital (WDC), Allegro (ALG), Arxis (ARXS), and Onto Innovation (ONTO).
Analysts made several calls: Wells Fargo initiated Blackrock (BLK) as overweight, citing its industry leadership. KeyBanc upgraded Airbnb (ABNB) to overweight, highlighting growth and AI benefits. Morgan Stanley named Nvidia (NVDA) a top pick, praising its recent developments. RBC upgraded Arxis (ARXS) to outperform, noting M&A upside. Piper Sandler upgraded Alerus Financial (ALRS) to overweight, expecting EPS upside.
Analysts updated ratings and price targets for several companies. Abbott Labs (ABT) was upgraded to buy with a $127 target. Airbnb (ABNB) was upgraded to overweight with a $191 target. HPE (HPE) was upgraded to outperform with a raised target to $75. Northrop Grumman (NOC) was downgraded to sector perform with a reduced target to $525. Other companies received mixed recommendations and target adjustments.